Farmers and Merchants Bancshares 3Q 2026: Revenue $7.69M, EPS $0.62 — 10-Q Summary

Farmers and Merchants Bancshares reported 3Q 2026 revenue of $7.69M, up 11.4% YoY, with net income rising 18.7% to $2.03M. EPS increased to $0.62. Growth was driven by higher loan interest income and lower credit losses, offsetting higher expenses. Net loans grew 3.5% from December 2025.

Original reporting
Published Nov 13, 2026, 9:51 PM UTC
Analysis
AlphAI AI DeskAI-generated
Added to AlphAI Nov 13, 2026, 10:01 PM UTC. Informational, not investment advice.
How this was made
AlphAI summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Farmers and Merchants Bancshares 3Q 2026: Revenue $7.69M, EPS $0.62 — 10-Q Summary — source image
Decision brief

The 30-second read

$FMFGNeutralLow
01

Why it matters

The earnings release provides the first public numbers for the quarter, offering a fresh data point for traders.

02

Market read

Micro‑cap bank earnings may attract niche investors but are unlikely to move broader indices.

03

What to watch

Potential risk from rising loan growth and watch‑list loans totaling $47M may affect future credit quality.

Relevance 6/10Novelty 7/10Timing: post‑market filing

Background

The article is an AI‑generated summary of the company's 10‑Q filing, highlighting key financial metrics for Q3 2026.

Company-level read

Ticker impact

$FMFGNeutralMedium confidence
Context

Farmers & Merchants Bancshares reported Q3 2026 results with revenue $7.69M and EPS $0.62 in its 10‑Q filing.

Expected impact

likely modest upside as earnings exceed prior quarter, but limited by small market cap

Evidence & confidence

The company posted 11.4% revenue growth and 18.7% net income increase, with no credit loss provision, which may attract short‑term buying interest.

Market effects

Shows strength in regional banking net interest margins, but impact limited to small‑cap community banks.

Minor effect on U.S. regional bank sector; no broader market move expected.

None

Counterpoint

Despite earnings beat, the bank's small scale and higher non‑interest expenses could limit upside.

Key entities

  • Farmers & Merchants Bancshares, Inc.

    U.S. regional bank reporting Q3 2026 results.

Related articles

$FMFGMed

FARMERS AND MERCHANTS BANCSHARES, INC. REPORTS EARNINGS OF $5.7 MILLION OR $1.76 PER SHARE FOR THE NINE MONTHS ENDED

Farmers & Merchants Bancshares, Inc. (FMFG) filed an SEC Form 8-K — Results of Operations and Financial Condition. Exhibit 99.1 FOR IMMEDIATE RELEASE FOR FURTHER INFORMATION CONTACT: October 22, 2026 Farmers and Merchants Bancshares, Inc. Contact: Mr. Gary A. Harris 4510 Lower Beckleysville Rd, Suite H President and Chief Executive Officer Hampstead, Maryland 21074 (410) 374-1510, ext. 1104 F

$FMFGMed

FARMERS AND MERCHANTS BANCSHARES, INC. REPORTS EARNINGS OF $3.7 MILLION OR $1.14 PER SHARE FOR THE SIX MONTHS ENDED

Farmers & Merchants Bancshares, Inc. (FMFG) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.1 2 ex_991668.htm EXHIBIT 99.1 ex_991668.htm Exhibit 99.1 FOR IMMEDIATE RELEASE FOR FURTHER INFORMATION CONTACT: July 23, 2026 Farmers and Merchants Bancshares, Inc. Contact: Mr. Gary A. Harris 4510 Lower Beckleysville Rd, Suite H President and Chief Executive Officer Hamps

$NMAXMed

Why Newsmax Stock Popped on Friday

Newsmax (NMAX) shares rose 31% after reporting Q3 revenue of $69M, up 52.5% YoY, and net income of $15.2M. The company cited strong audience engagement and growth in high-margin revenue streams. CEO Christopher Ruddy expects continued growth ahead of the presidential election.

$LUNRMed

What Is Driving Intuitive Machines Stock?

Intuitive Machines (LUNR) shares rose 7.0% on Nov 12, 2026, after reporting Q3 revenue of $269M, beating estimates. The company's loss of $0.10 per share met expectations, while gross margin improved to 26%. Free cash flow turned positive at $33M, a company record. Management raised full-year revenue guidance to $920M-$950M. The stock's performance contrasted with broader industry declines.

$RMIXMedAI 8/10

Suncrete (RMIX) Q3 2026 Earnings Call Transcript

Suncrete (RMIX) reported Q3 2026 revenue of $141M, up 45% QoQ and 163% YoY. Adjusted EBITDA rose 66% QoQ to $22.4M. The company lowered its full-year outlook due to residential construction weakness but remains confident in long-term demand. Acquisition integration is progressing, with North Texas showing margin improvement. Suncrete expects $200M-$250M revenue from 2026 acquisitions in 2027. The company has $206.5M in total liquidity.

$CLLSMed

Cellectis SA (CLLS) (Q3 2026) Earnings Call Highlights: Strategic Shift to Gene

Cellectis SA (CLLS) discussed its strategic shift to gene editing during its Q3 2026 earnings call. Management highlighted the selection of APOC3 over ANGPTL3 for triglyceride reduction, with plans to start Phase 1 dosing by end-2027. The company reported $149M in cash as of September 30, 2026, with a runway into H2 2028. Revenue decreased to $19.9M from $67.4M YoY, while R&D expenses increased to $108.8M from $69.1M, driven by the AstraZeneca collaboration.